GB0203197D0 - Delta opioid agonists - Google Patents
Delta opioid agonistsInfo
- Publication number
- GB0203197D0 GB0203197D0 GBGB0203197.9A GB0203197A GB0203197D0 GB 0203197 D0 GB0203197 D0 GB 0203197D0 GB 0203197 A GB0203197 A GB 0203197A GB 0203197 D0 GB0203197 D0 GB 0203197D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- opioid agonists
- delta opioid
- delta
- agonists
- opioid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0105098.8A GB0105098D0 (en) | 2001-03-01 | 2001-03-01 | Compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0203197D0 true GB0203197D0 (en) | 2002-03-27 |
GB2374074A GB2374074A (en) | 2002-10-09 |
Family
ID=9909792
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0105098.8A Ceased GB0105098D0 (en) | 2001-03-01 | 2001-03-01 | Compounds |
GB0203197A Withdrawn GB2374074A (en) | 2001-03-01 | 2002-02-11 | Thiazolyl-benzyl-piperazines for treating gastrointestinal disorders |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0105098.8A Ceased GB0105098D0 (en) | 2001-03-01 | 2001-03-01 | Compounds |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB0105098D0 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109575017A (en) * | 2018-11-01 | 2019-04-05 | 山东蒲济医药科技有限公司 | A kind of preparation method of Olprinone HCl compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0013346D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
-
2001
- 2001-03-01 GB GBGB0105098.8A patent/GB0105098D0/en not_active Ceased
-
2002
- 2002-02-11 GB GB0203197A patent/GB2374074A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2374074A (en) | 2002-10-09 |
GB0105098D0 (en) | 2001-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60223590D1 (en) | Reaktionsenergieaufnahmesystem | |
AU2002350244A8 (en) | Pyridoquinoxaline antivirals | |
IL158051A0 (en) | Somatostatin agonists | |
IL160751A (en) | Muscarinic agonists | |
GB0120051D0 (en) | Oxytocin agonists | |
AU2002359464A8 (en) | Angiopioetin related factors | |
DE60204140D1 (en) | 5-ethyl-imidazotriazinone | |
IL162443A (en) | Imidazoquinoline derivatives | |
AU150241S (en) | Lollipop | |
GB0203197D0 (en) | Delta opioid agonists | |
GB0100862D0 (en) | Reflactron | |
GB0122162D0 (en) | Agent | |
GB0106987D0 (en) | Immunotherapeuitic agent | |
GB2381963B (en) | Terminal | |
AU146999S (en) | Base | |
GB0110156D0 (en) | Positioning | |
TW574995U (en) | Structure for mini-bicycle | |
GB0125051D0 (en) | GT speedlock | |
AU3099P (en) | Gan01 Cordyline fruticosa | |
GB0101134D0 (en) | Inhibitors | |
GB0128453D0 (en) | Inhibitors | |
GB0101135D0 (en) | Inhibitors | |
GB0106487D0 (en) | Agent | |
AU145332S (en) | Frypan base | |
HU0103282D0 (en) | Round-sewing-machine for haemorrhoidectomy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |